Test Price
450 AED✅ Home Collection Available
Immunophenotyping by Flow Cytometry (CD20) Test in UAE | 450 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Collection Protocol: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. Specimens must be maintained at 18–22°C and transported immediately; do not refrigerate or freeze.
- Clinical Guidance: Complimentary telephonic post-test clinical guidance for result interpretation by DHA-licensed physicians.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The CD20 Immunophenotyping by Flow Cytometry test quantifies CD20-positive B lymphocytes in blood or bone marrow, aiding in the diagnosis, classification, and monitoring of B-cell lymphomas and leukemias in the UAE. This test employs advanced multicolor flow cytometry to deliver precise, actionable results for oncologists and hematologists. The methodology is fully compliant with ICSH/ICCS standards.
| Feature | Our CD20 Flow Cytometry | Standard Alternative |
|---|---|---|
| Precision | Multicolor 8-parameter analysis with CD20 monoclonal antibody panel, minimal inter-operator variability | Single- or dual-color analysis, less granularity |
| Methodology | Fluorescent Flow Cytometry (ICSH/ICCS compliant) | Manual immunocytochemistry or limited flow |
| TAT | Same-day report when sample received by 9 AM | 24–48 hours |
Physician Insight & Safety Protocols
“Immunophenotyping provides critical information for targeted therapy decisions in B-cell malignancies. However, results must be correlated with imaging findings and histopathology for a complete diagnostic picture. Avoid isolated interpretation – always integrate with the full clinical context.”
— Mr. Prabhakar Reddy Kalathoor (Specialist Diagnostic Radiology, DHA Registration ID: 61713011)
Medication Advisory
Do not alter or discontinue any prescribed medications without consulting your physician. Anti-CD20 therapies (e.g., rituximab) can significantly affect CD20 expression levels and test interpretation. Always provide a complete medication history to the requesting clinician.
Exclusion Criteria & Emergency Red Flags
- Active severe infection or sepsis – postpone collection until clinically stable.
- Severe thrombocytopenia (platelets < 20 × 10⁹/L) with high bleeding risk, unless cleared by a hematologist.
- Development of sudden high fever, altered consciousness, or uncontrolled bleeding after sample collection requires immediate emergency evaluation.
Patient FAQ & Clinical Guidance
1. What does the CD20 immunophenotyping test detect and why is it important?
This test measures the percentage and absolute count of CD20-positive B lymphocytes. It is essential for diagnosing B-cell lymphomas (e.g., diffuse large B-cell lymphoma, chronic lymphocytic leukemia) and for monitoring response to targeted therapies like rituximab.
2. How should I prepare for the sample collection?
No fasting is required. Provide a brief clinical history including any known diagnosis and current medications. The sample (blood or bone marrow) must be kept at 18–22°C and transported to the lab immediately; do not refrigerate or freeze.
3. How quickly will I receive the results and who interprets them?
Results are reported on the same day if the sample reaches our lab by 9 AM. A DHA-licensed hematologist or oncologist will interpret the report and provide telephonic guidance to help you understand the clinical implications.
UAE Regulatory & Data Privacy Adherence
This test and associated data handling are fully compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Laboratory operations are ISO 9001:2015 accredited (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | Immunophenotyping by Flow Cytometry (CD20) |
| Price (AED) | 450 |
| Turnaround Time | Same-day (sample received by 9 AM) |
| Sample Type / Matrix | Whole blood (EDTA and Sodium Heparin) or Bone marrow (Sodium Heparin). Collection: Hospital Extraction Only – requires accredited facility. |
| Methodology Used | Multicolor Flow Cytometry (ICSH/ICCS compliant) |
| ICD-10-CM Code | C83.9 |
| LOINC Code | 14678-2 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | DNA Labs UAE | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians